Â
D. Csanyi et al. / Bioorg. Med. Chem. Lett. 10 (2000) 1767±1769
1768
acid at re¯ux temperature (i.e., preparation of the
amino compound 6 prepared earlier by Rocca et al.10 by
an independent route), and subsequent diazotation gave
the diazonium salt 7. Treatment with sodium azide
under weakly basic conditions (sodium acetate buer)
aorded the azide 811 in 66% yield. Heat-treatment of 8
gave rise to formation (by generation of a nitrene) of the
desired pentacyclic compound 3 in 58% yield which
proved to be identical (NMR spectrum and mp)12 with
the sample obtained from 1. In order to obtain a deri-
vative of this new ring system suitable for biological
investigations 3 was methylated by trimethyloxonium
tetra¯uoroborate in dichloromethane to give the 5-
methyl substituted salt (9)13 in good yield.
several measurements signi®cantly revealed that the
methyl substituted compound 9 is highly active: a Tm
point increase of 20.6 ꢀC was found, while the triazi-
nium salt 10 proved to be inactive.
Extension of the synthesis for further related derivatives
as well as detailed biological investigation of the new
heterocyclic ring systems is in progress.
Acknowledgements
The funds OTKA 2211, 26476 and ®nancial support from
the French Ministry of Education and Research (these
co-tutelle for D.C.) are gratefully acknowledged.
References and Notes
1. Molina, P.; Vilaplana, M. J. Synthesis, 1994, 1197.
2. Nagy, T.; Jeannin, L.; Sapi, J.; Laronze, J.-Y.; Renard, P.;
Pfeier, B.; Bizot-Espiard, J.-G. Eur. J. Med. Chem. 1995, 30, 575.
1
3. (2) H NMR (CDCl3 300 MHz) d ppm 8.25 (NH, s, 1H),
7.83 (H5, dd, 7 Hz, 1.8 Hz, 1H), 7.52 (H30, dd, 9 Hz, 2 Hz,
1H), 7.41 (H60, dd, 9 Hz, 1.7 Hz, 1H), 7.4±7.12 (m, 4H), 7.33
(H8, dd, 7.2 Hz, 1.6 Hz, 1H), 5.65 (H1, s, 1H), 3.15 (H3, m,
2H), 2.87 (H4, m, 2H); 13C NMR (CDCl3 75 MHz) d ppm
149.8, 136.4, 135.9, 132.9, 132.2, 131.2, 128.6, 126.9, 124.2,
122.0, 119.5,118.3, 111.1, 110.9, 52.0, 41.6, 22.1.
4. Julino, M.; Stevens, M.F.G. J. Chem. Soc. Perkin 1 1998,
1677.
5. Pastor, J.; Siro, J.; Garcia-Navio, J. L.; Rodrigo, M. M.;
Ballesteros, M.; Alvarez-Builla, J. Bioorg. Med. Chem. Lett.
1995, 5, 3043.
6. (a) Timari, G.; Soos, T.; Hajos, Gy.; Messmer, A.; Nacsa,
J.; Molnar, J. Bioorg. Med. Chem. Lett. 1996, 6, 2831. (b)
Timari, G. Soos, T.; Hajos, Gy. Synlett 1997, 1067.
7. Csanyi, D.; Timari, G.; Hajos, Gy. Synth. Commun. 1999,
29, 3959.
8. Formation of this compound in a mixture of O- and N-
tri¯ic isomers has been reported: Bracher, F.; Hildebrand, D.;
Ludger, E. Arch. Pharm. (Weinheim) 1994, 327, 121. We have
obtained the pure tri¯ate by treating 4 with tri¯ic anhydride in
pyridine at room temperature, mp 103±5 ꢀC; 71%.
9. Suzuki-coupling to 1-chloro-b-carboline has already been
published: Bracher, F.; Hildebrand, D.; Liebigs Ann. Chem.
1992. 1315.
An interesting extension of this synthetic work was pro-
vided by investigating the intermediate diazonium salt 7 in
more detail. In one of our early studies14 we described that
o-substituted a-pyridylphenyldiazonium salts can form a
valence bond isomeric equilibrium with a fused v-triazi-
nium salt, and these equilibria can be sensitively shifted
by changing the substituents. In order to check whether
or not such a ring closure of 7 takes place the product of
the diazotation reaction of 6 was also isolated in crys-
talline form (mp 130±2oC; 96%)15 and was investigated
by IR and NMR spectroscopy. These spectra unam-
biguously revealed that the isolated product is entirely
in the triazinium form 10, and neither the crystals nor its
solutions contain detectable amount of the diazonium
isomer 7. To the best of our knowledge, this ring closed
product: benzo[40,50][1,2,3]triazino[6,1-a]-b-carbolinium
salt (10) also represents a new ring system. It is inter-
esting to note that two fused quaternary ring systems
closely related to 10: pyrido[2,1-a]-b-carbolinium and
pyridazino[3,2-a]-b-carbolinium salts have been descri-
bed and proved to be potent antitumor compounds.16,17
10. Arzel, E.; Rocca, P.; Marsais, F.; Godard, A.; Queguiner,
G. J. Heterocycl. Chem. 1997, 34, 1205.
11. (8) 1H NMR (CDCl3+C6H6-d6 400 MHz) d ppm 8.54
(H3, d, 5 Hz, 1H), 8.22 (NH, s, 1H), 8.04 (H5, m, 1H), 7.84
(H4, d, 5 Hz, 1H), 7.56 (H30, m, 1H), 7.42 (H7, td, 7 Hz, 1 Hz,
1H), 7.33 (H50, m, 1H), 7.25 (H8, dt, 8 Hz, 1 Hz, 1H), 7.21
(H6, td, 7 Hz, 1 Hz, 1H), 7.17 (H40, t, 6.5 Hz, 1H), 7.16 (H60,
d, 7.5 Hz, 1H); 13C NMR (CDCl3) d ppm 140.7, 140.6, 139.4,
138.1, 134.5, 132.3, 130.5, 130.3, 129.7, 128.8, 125.6, 122.0,
121.9, 120.4, 119.1, 114.5, 111.8;, IR (KBr) n cm 1 2126, 2095,
1626, 1497, 1321, 1298, 1238, 748.
The fact that an equilibrium between 7 and 10 exists is
also revealed by the ®nding that treatment of the ring-
closed 10 with sodium azide under the same conditions
as in the transformation of the open-chained 7, the same
product (i.e., 8) was obtained.
12. (3) mp >240 ꢀC; 1H NMR (CDCl3+DMSO-d6 400 MHz)
d ppm 12.1 (NH, s, 1H), 8.62 (H4, dd, 8 Hz, 1 Hz, 1H), 8.54
(H7, d, 7Hz, 1H), 8.00 (H9, d, 8 Hz, 1H), 7.79 (H8, d, 7 Hz,
1H), 7.70 (H1, d, 8 Hz, 1H), 7.62 (H12, dd, 8 Hz, 1 Hz, 1H),
7.43 (H2, td, 8Hz, 1Hz, 1H), 7.35 (H11, m, 1H), 7.20 (H10, td,
7 Hz, 1 Hz, 1H), 7.17 (H3, td, 8 Hz, 1 Hz, 1H); 13C NMR
(CDCl3) d ppm 147.4, 138.6, 128.3, 126.1, 123.9, 123.5, 121.0,
119.9, 119.1, 119.0, 118.4, 118.0, 113.7, 113.4, 112.8, 110.7,
108.4; IR (KBr) n cm 1 3307, 1542, 1456, 1377, 1367, 1212, 725.
The intercalating property of the two new water-soluble
polycycles (9 and 10) was investigated by determination
of the increase of Tm point.18 As a model DNS, T20±
dA20 duplex was used19 (Tm=45.7 ꢀC) The results of